Artículos por temáticas

Epigenetic regulation of iron metabolism and ferroptosis in Parkinson's disease: Identifying novel epigenetic targets

Gao XD, Ding JE, Xie JX, Xu HM.

Acta Pharmacol Sin. 2025 Aug;46(8):2075-2092. doi: 10.1038/s41401-025-01499-6. Epub 2025 Mar 11.

Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study

Orrú CD, Vaughan DP, Vijiaratnam N, Real R, Martinez-Carrasco A, Fumi R, Jensen MT, Hodgson M, Girges C, Gil-Martinez AL, Stafford EJ, Wu L, Lerche S, Wurster I, Groveman BR, Hughson AG, Ansorge O, Qu

Lancet Neurol. 2025 Jul;24(7):580-590. doi: 10.1016/S1474-4422(25)00157-7.

Cognitive disorders and parkinson's disease: a literature review

Jamora RDG, Untalan LGV, Santiago DMLB, Tan LCS.

J Neural Transm (Vienna). 2025 Jul 18. doi: 10.1007/s00702-025-02983-3. Online ahead of print.

Rehabilitation Strategies for Sleep and Autonomic Symptoms in Parkinson's Disease

Kamo H, Nagaki K, Warren L, Kraus AR, Okun MS, Wagle Shukla A.

Curr Neurol Neurosci Rep. 2025 Jul 8;25(1):47. doi: 10.1007/s11910-025-01433-7.

Microglial immune memory in Parkinson's and Huntington's diseases: epigenetics, triggers, and therapies

Chowdhury R, Hendlinger A, Riess O, Schulze-Hentrich J.

Epigenomics. 2025 Aug;17(11):739-751. doi: 10.1080/17501911.2025.2518909. Epub 2025 Jul 1.

Parkinson's Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation

Tanaka M.

Cells. 2025 Jul 28;14(15):1161. doi: 10.3390/cells14151161.

Brain photobiomodulation: a potential treatment in Alzheimer's and Parkinson's diseases

Blivet G, Touchon B, Cavadore H, Guillemin S, Pain F, Weiner M, Sabbagh M, Moro C, Touchon J.

J Prev Alzheimers Dis. 2025 Aug;12(7):100185. doi: 10.1016/j.tjpad.2025.100185. Epub 2025 Apr 25.

Precision medicine and music therapy for Parkinson's Disease

Li-Hua P, Jallow L, Tan Y, Bajinka O.

Clin Park Relat Disord. 2025 Aug 6;13:100382. doi: 10.1016/j.prdoa.2025.100382. eCollection 2025.

Sarcopenia in Parkinson's disease: from pathogenesis to interventions

Gui M, Lv L, Hu S, Qin L, Wang C.

Metabolism. 2025 Aug;169:156272. doi: 10.1016/j.metabol.2025.156272. Epub 2025 Apr 19.

Innovations in Parkinson's Disease: Strategies and Novel Technologies

Sha R, Dabus MA, Torres-Russotto DR, Bhakuni N, Dabus GC.

Cureus. 2025 Jul 5;17(7):e87309. doi: 10.7759/cureus.87309. eCollection 2025 Jul.

Genetics of Parkinson's Disease: From Causes to Treatment

Westenberger A, Brüggemann N, Klein C.

Cold Spring Harb Perspect Med. 2025 Jul 1;15(7):a041774. doi: 10.1101/cshperspect.a041774.

Gene-modified animal models of Parkinson's disease

Peng Y, Jiang DY, Yao SY, Zhang X, Kazuo S, Liu J, Du MQ, Lin LX, Chen Q, Jin H.

Exp Neurol. 2025 Aug;390:115287. doi: 10.1016/j.expneurol.2025.115287. Epub 2025 May 4.

Vascular parkinsonism: an update

Jellinger KA.

J Neural Transm (Vienna). 2025 Jul;132(7):899-919. doi: 10.1007/s00702-025-02960-w. Epub 2025 Jun 5.

Causal relationship between immune mediators and parkinson's disease: A Mendelian randomization analysis

Qiu R, Su Y, Pan L, Fan K, Sun Z, Liang Y, Lin X, Zhang Y.

Sci Rep. 2025 Jul 10;15(1):24884. doi: 10.1038/s41598-025-11198-1.

Neuropsychiatric disorders in Parkinson's disease

Heim B, Djamshidian A.

Ther Adv Neurol Disord. 2025 Jul 28;18:17562864251356062. doi: 10.1177/17562864251356062. eCollection 2025.